Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Evotec AG Evotec AG" found in our extensive corporate database of over 50,000 company records.
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, cove...
Evotec has considerable technical expertise and manufacturing know-how. Evotec specialise in drug formulation development and the manufacture of clinical trial supplies for biotechnology and pharmaceutical clients around the world. We have built a strong team of forty highly skilled employees who collectively can assist you in achieving your goals. We recently added further laboratories and manufa...
Evotec has established itself as the partner of choice for the worlds leading pharmaceutical and biotechnology companies by providing them with high quality, successful and innovative solutions throughout the drug discovery and development value chain.We achieve this success by using an unmatched range of state-of-the-art integrated capabilities, including early stage assay development, compound s...
The company provides seamless integration of hardware, software and bioware modules, combining cutting-edge technologies for measurement, miniaturisation and automation. EVOscreen®, the high resolution uHTS system, represents only the most prominent example of elegant solutions resulting from this approach. Recombining validated core technologies, the company wants to serve current and future nee...
ARTEMIS Pharmaceuticals, based in Cologne Germany was founded in 1998 and has made significant advances to provide rapid, efficient and sophisticated techniques for the analysis of gene function in vertebrates.We are a wholly-owned subsidiary of Exelixis Inc., South San Francisco CA (NASDAQ: EXEL), but operate a distinct business model. Our activities are dedicated towards the provision of transge...